Company registration number 03973881 (England and Wales)
REGENT HEALTHCARE LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
REGENT HEALTHCARE LIMITED
COMPANY INFORMATION
Directors
P A Barton
C V Bettinson
Company number
03973881
Registered office
MRIB House
25 Amersham Hill
High Wycombe
Buckinghamshire
HP13 6NU
Accountants
Beavis Morgan LLP
82 St John Street
London
EC1M 4JN
REGENT HEALTHCARE LIMITED
CONTENTS
Page
Directors' report
1
Statement of comprehensive income
2
Balance sheet
3
Statement of changes in equity
4
Notes to the financial statements
5 - 10
REGENT HEALTHCARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -
The directors present their annual report and financial statements for the year ended 31 March 2025.
Results and dividends
The results for the year are set out on page 2.
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
P A Barton
C V Bettinson
On behalf of the board
P A Barton
Director
27 November 2025
REGENT HEALTHCARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
2025
2024
Notes
£
£
Turnover
3
-
11,093
Administrative expenses
(38,800)
Loss before taxation
(27,707)
Tax on loss
7
10,923
Loss for the financial year
(16,784)
The profit and loss account has been prepared on the basis that all operations are continuing operations.
REGENT HEALTHCARE LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 3 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
9
63,169
63,169
Creditors: amounts falling due within one year
10
(75,427)
(75,427)
Net current liabilities
(12,258)
(12,258)
Capital and reserves
Called up share capital
11
120
120
Profit and loss reserves
(12,378)
(12,378)
Total equity
(12,258)
(12,258)
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The financial statements were approved by the board of directors and authorised for issue on 27 November 2025 and are signed on its behalf by:
P A Barton
Director
Company registration number 03973881 (England and Wales)
REGENT HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 April 2023
120
4,406
4,526
Year ended 31 March 2024:
Loss and total comprehensive income
-
(16,784)
(16,784)
Balance at 31 March 2024
120
(12,378)
(12,258)
Year ended 31 March 2025:
Profit and total comprehensive income
-
Balance at 31 March 2025
120
(12,378)
(12,258)
REGENT HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
1
Accounting policies
Company information
Regent Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is MRIB House, 25 Amersham Hill, High Wycombe, Buckinghamshire, HP13 6NU.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
The financial statements of the company are consolidated in the financial statements of Partners& Group Limited. These consolidated financial statements are available from its registered office, MRIB House, 25 Amersham Hill, High Wycombe, Buckinghamshire, HP13 6NU.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
1.4
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.
1.5
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.
REGENT HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 6 -
1.6
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.7
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
REGENT HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 7 -
1.9
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
3
Turnover
2025
2024
£
£
Turnover analysed by class of business
Brokerage
-
11,093
4
Operating profit/(loss)
2025
2024
Operating profit/(loss) for the year is stated after charging:
£
£
Exchange (gains)/losses
60
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
0
1
REGENT HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
5
Employees
(Continued)
- 8 -
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
34,000
Social security costs
-
3,632
37,632
6
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
34,000
7
Taxation
2025
2024
£
£
Current tax
Adjustments in respect of prior periods
(3,996)
Group tax relief
(6,927)
Total current tax
(10,923)
The actual charge/(credit) for the year can be reconciled to the expected credit for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit/(loss) before taxation
(27,707)
Expected tax charge/(credit) based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
(6,927)
Under/(over) provided in prior years
(3,996)
Taxation charge/(credit) for the year
-
(10,923)
REGENT HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
8
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
137,245
Amortisation and impairment
At 1 April 2024 and 31 March 2025
137,245
Carrying amount
At 31 March 2025
At 31 March 2024
9
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
2,540
2,540
Amounts owed by group undertakings
58,946
58,946
Prepayments and accrued income
1,683
1,683
63,169
63,169
10
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
55,367
55,367
Amounts owed to group undertakings
10,145
10,145
Other creditors
9,015
9,015
Accruals and deferred income
900
900
75,427
75,427
11
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
120
120
120
120
REGENT HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 10 -
12
Ultimate controlling party
The parent company of Regent Healthcare Limited is Partners& Holdings Limited and its registered office is MRIB House, 25 Amersham Hill, High Wycombe, Buckinghamshire, HP13 6NU.
The financial statements of the company are consolidated in the financial statements of Partners& Group Limited. These consolidated financial statements are available from its registered office, MRIB House, 25 Amersham Hill, High Wycombe, Buckinghamshire, HP13 6NU. This is the smallest and largest group into which the company is consolidated.
2025-03-312024-04-01falsefalsetrueCCH SoftwareCCH Accounts Production 2025.300No description of principal activityP A BartonC V Bettinson039738812024-04-012025-03-3103973881bus:Director12024-04-012025-03-3103973881bus:Director22024-04-012025-03-3103973881bus:RegisteredOffice2024-04-012025-03-31039738812025-03-31039738812023-04-012024-03-3103973881core:RetainedEarningsAccumulatedLosses2023-04-012024-03-3103973881core:RetainedEarningsAccumulatedLosses2024-04-012025-03-31039738812024-03-3103973881core:WithinOneYear2025-03-3103973881core:WithinOneYear2024-03-3103973881core:CurrentFinancialInstruments2025-03-3103973881core:CurrentFinancialInstruments2024-03-3103973881core:ShareCapital2025-03-3103973881core:ShareCapital2024-03-3103973881core:RetainedEarningsAccumulatedLosses2025-03-3103973881core:RetainedEarningsAccumulatedLosses2024-03-3103973881core:ShareCapital2023-03-3103973881core:RetainedEarningsAccumulatedLosses2023-03-3103973881core:ShareCapitalOrdinaryShareClass12025-03-3103973881core:ShareCapitalOrdinaryShareClass12024-03-3103973881core:Goodwill2024-04-012025-03-3103973881core:UKTax2024-04-012025-03-3103973881core:UKTax2023-04-012024-03-310397388112024-04-012025-03-310397388112023-04-012024-03-3103973881core:Goodwill2024-03-3103973881core:Goodwill2025-03-3103973881core:Goodwill2024-03-3103973881bus:OrdinaryShareClass12024-04-012025-03-3103973881bus:OrdinaryShareClass12025-03-3103973881bus:OrdinaryShareClass12024-03-3103973881bus:EntityNoLongerTradingButTradedInPast2024-04-012025-03-3103973881bus:PrivateLimitedCompanyLtd2024-04-012025-03-3103973881bus:Micro-entities2024-04-012025-03-3103973881bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3103973881bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP